The Homeoprotein DLX4 Stimulates NF-κB Activation and CD44-Mediated Tumor–Mesothelial Cell Interactions in Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Homeoprotein DLX4 Stimulates NF-κB Activation and CD44-Mediated Tumor–Mesothelial Cell Interactions in Ovarian Cancer

Published:2015-08 Issue:8 Volume:185 Page:2298-2308
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Haria Dhwani,Trinh Bon Quy,Ko Song Yi,Barengo Nicolas,Liu Jinsong,Naora Honami

Funder

Cancer Prevention and Research Institute of Texas

National Institutes of Health

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Ovarian cancer: strategies for overcoming resistance to chemotherapy;Agarwal;Nat Rev Cancer,2003

3. Ovarian cancer metastasis: integrating insights from disparate model organisms;Naora;Nat Rev Cancer,2005

4. Ovarian cancer development and metastasis;Lengyel;Am J Pathol,2010

5. Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis;Sodek;Cancer Metastasis Rev,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-κB/CD44 pathway inhibition;iScience;2024-06

2. SHFM1 deficiency suppresses esophageal squamous cell carcinomas progression via modulating NF‑κB signaling and enhancing nature killer cell‑mediated tumor surveillance;Experimental and Therapeutic Medicine;2023-03-17

3. Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma;Oncology Letters;2023-02-28

4. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer;Frontiers in Immunology;2022-10-04

5. DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis;Cellular & Molecular Biology Letters;2022-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3